Hansoh Pharmaceutical (03692) Terminates Post-IPO Restricted Share Unit Plan and Proposes Adoption of 2026 Share Plan

Hansoh Pharma (03692) announced that on April 28, 2026, the board of directors resolved to terminate the company's restricted share unit plan adopted on May 27, 2019, after the initial public offering, and proposed to seek approval from the company’s shareholders for the adoption of the 2026 Share Plan at the subsequent annual general meeting of shareholders. The effective date of the termination of the existing restricted share unit plan will be the date when the new share plan is adopted.